ASP ISOTOPES INC (ASPI)
Materials · Advanced Materials & Isotopes · NASDAQ
An advanced materials firm specializing in isotope enrichment for semiconductors, medicine, and nuclear energy, currently pivoting toward commercial production and subsidiary spin-offs.
What ASP ISOTOPES INC does
ASP Isotopes Inc. is an advanced materials company that develops proprietary technology for the enrichment of isotopes for use in the semiconductor, healthcare, and energy industries. Its operations include a PET Labs group for medical isotopes, the development of stable isotopes like Silicon-28 and Ytterbium-176, nuclear fuel production through its subsidiary Quantum Leap Energy, and helium and LNG production via its interests in Renergen. The company is actively restructuring its portfolio through potential spin-offs and reverse mergers of its subsidiaries to unlock shareholder value.
Recent developments
The company is pursuing a reverse merger for its subsidiary, Noble Africa (Renergen), with ENDRA Life Sciences to gain public market access. It is also progressing toward shipping its first commercial Silicon-28 and Ytterbium-176 products and expects to commence helium production at its Renergen operations by late 2026. Additionally, the company is preparing its nuclear fuels subsidiary, Quantum Leap Energy, for a potential separate public listing.
From ASP ISOTOPES INC's filing of 2026-08-14.
Themes: isotope enrichment, semiconductor materials, nuclear energy, medical imaging / PET, helium supply chain, corporate spin-offs / restructurings
Fundamentals
- Price$2.03 as of 2026-10-20 close
- Market cap$311M as of 2026-08-14 (share count; price 2026-10-20)
- 1-year return-80.2% 2025-10-20 close $10.26 → 2026-10-20 close $2.03
- P/En/a negative earnings
- Net margin-670.2% FY2025, SEC XBRL
- Gross margin+14.3% FY2025, SEC XBRL
- ROE-78.3% FY2025, SEC XBRL
- ROICn/a No figure: its pre-tax income was zero or negative, so there is no tax rate to apply.
- Debt / equity0.23 borrowings, leases excluded / equity — 10-Q/10-K balance sheet 2026-06-30
- Revenue growth (YoY)+475.5% FY2025, SEC XBRL
- Beta2.50 as of 2026-09-03
- Last reported earnings2026-08-04 SEC EDGAR Form 8-K (Item 2.02)
How ASPI compares in its sector
- net profit marginbottom 10% 125 covered Materials peers, as of 2026-09-03
- operating marginbottom 10% 108 covered Materials peers, as of 2026-09-03
- gross marginbottom 25% 92 covered Materials peers, as of 2026-09-03
- return on equitybottom 10% 144 covered Materials peers, as of 2026-09-03
- free cash flow (absolute dollars, latest fiscal year)bottom 25% 122 covered Materials peers, as of FY2025
Position among covered Materials companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Dividend coverage
Not assessed — last reported dividend predates the accounts. The most recent fiscal year in which ASPI reported a dividend payment is FY2024, while its reported financial statements run through FY2025. Coverage is therefore not assessed for the latest year — an FY2024 ratio would not describe ASPI today.
Coverage is derived from reported SEC EDGAR XBRL figures, comparing dividends paid against net income and free cash flow for the SAME fiscal year. It is not shown here because the latest fiscal year with a reported dividend payment (FY2024) is older than the latest year of reported financial statements (FY2025), so any ratio would describe an out-of-date year. Informational only — not financial advice.
Quarterly results
| Quarter | Revenue | Gross profit | Operating income | Net income | Diluted EPS | Operating cash flow | Capex |
|---|---|---|---|---|---|---|---|
| Q2 FY2026 2026-06-30 | $5M | $1M | -$34M | -$34M | -$0.27 | -$23M† | $4M† |
| Q1 FY2026 2026-03-31 | $4M | $2M | -$25M | -$7M | -$0.06 | -$18M | $6M |
| Q4 FY2025 2025-12-31 | $17M† | $2M† | -$25M† | -$63M† | -$0.84† | -$18M† | $2M† |
| Q3 FY2025 2025-09-30 | $5M | $423178 | -$15M | -$13M | -$0.15 | -$9M† | $3M† |
| Q2 FY2025 2025-06-30 | $1M | $572000 | -$12M | -$75M | -$1.03 | -$8M† | $2M† |
| Q1 FY2025 2025-03-31 | $1M | $327000 | -$8M | -$8M | -$0.12 | -$3M | $2M |
| Q4 FY2024 2024-12-31 | $1M† | $605125† | -$8M† | -$9M† | -$0.13† | -$4M† | $1M† |
| Q3 FY2024 2024-09-30 | $1M | $293981 | -$5M | -$7M | -$0.12 | -$5M† | $4M† |
† Not filed as a discrete quarter: derived from the company's own year-to-date figures (for example the fourth quarter as the fiscal year minus the first nine months). A derived per-share figure is approximate, because the share count moves within the year.
Balance sheet at 2026-06-30
- Cash and equivalents$220M
- Short-term investments$35M
- Total debt$60M borrowings only; leases excluded
- Net debt-$195M total debt − cash − short-term investments
From the company's own SEC 10-Q and 10-K filings (XBRL), re-read every week. Figures in US dollars as filed; informational only — not financial advice.
How ASP ISOTOPES INC looks technically
ASP ISOTOPES INC (ASPI) is trading 59.6% below its 200-day average, the long-term trend line — a long-term downtrend. Its 50-day average crossed below its 200-day average about 203 trading days ago — a "death cross", a bearish long-term signal. A strong downtrend is in place — ADX, a 0–100 trend-strength gauge, is 48, with sellers in control. Momentum is beaten down — its 14-day RSI (a 0–100 momentum gauge) is 26, in oversold territory (below 30). MACD, a trend-momentum gauge, turned bearish about 6 trading days ago (its momentum flipped negative). It just made a new 20-day low, breaking below its recent trading range. It is 85.2% below its highest point of the past year.
Trend
8
| Distance from the 200-day | it is trading 59.6% below its 200-day average, the long-term trend line — a long-term downtrend | -59.6% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $3.31 | $3.31 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $5.03 | $5.03 |
| Swing structure | each recent peak has been lower than the one before it and each dip deeper — the pattern chart-watchers call a downtrend, which describes where price has already been and not where it goes next | lower highs and lower lows |
| Last swing turn | its last significant turn was a swing high 15 calendar days ago — the swings before that are what the structure reading is measured on | 15 sessions |
| Wave structure | its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 5 of five; the labelling fails if price closes above 3.055. It is the only labelling that fits, though not with textbook proportions, and it describes the swings already printed, not what comes next. | possible downward five-wave sequence, in wave 5 (atypical proportions) |
| Since the 50/200 cross | its 50-day average crossed below its 200-day average about 203 trading days ago — a "death cross", a bearish long-term signal | 203 sessions |
| Trend strength (14-day ADX) | a strong downtrend is in place — ADX, a 0–100 trend-strength gauge, is 48, with sellers in control | 48.2 |
Momentum
3
| 14-day RSI | momentum is beaten down — its 14-day RSI (a 0–100 momentum gauge) is 26, in oversold territory (below 30) | 25.9 |
|---|---|---|
| Position in its 14-day range | it is trading near the bottom of its 14-day range ($1.89 to $3.06) — its "stochastic" reading is 12 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been slipping within that range over the last few sessions. | 12.0 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bearish about 6 trading days ago (its momentum flipped negative) | 6 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $13.75 | $13.75 |
|---|---|---|
| From the 52-week high | it is 85.2% below its 52-week high (its highest price of the past year) | -85.2% |
| Above the 52-week low | it is 7.4% above its 52-week low (its lowest price of the past year) | +7.4% |
| Below the 52-week high | it is 85.2% below its highest point of the past year | 85.2% |
| Since a 20-day breakout | it just made a new 20-day low, breaking below its recent trading range | 1 session |
| Since a 55-day breakout | it just made a new 55-day low, breaking below its recent trading range | 1 session |
| All-time high | its highest closing price on record is $14.49 (set on 2025-10-14) | $14.49 |
| Given back of the 52-week move | over the past year its closes ranged ($2.03 to $12.62), and it has recovered essentially none of its fall from last year’s high — 0% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $8.57 to $8.91. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 0.0% |
| From the all-time high | it is 86.0% below its all-time high | -86.0% |
| Nearest price level | it is trading 78.8% below a resistance level at $3.63 — a price it turned at twice since 2025-03-04, most recently on 2026-07-17. Since 2024-10-21 it has 0 such levels below the current price and 17 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | +78.8% |
| All-time low | its lowest closing price on record is $0.28 (set on 2023-05-18) | $0.28 |
| Above the all-time low | it is 625.0% above its all-time low | +625.0% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are wider than usual versus its own recent 6-month history (wider than about 74% of it) | 74th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.2233 between its high and its low — about 11.0% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.2233 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $1.92 and $3.25 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $1.92 – $2.59 – $3.25 |
| Typical daily range (% of price) | its price moves about 11.0% in a typical session — among the most volatile in the catalog. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 11.0% |
| Stretch from the 200-day average | it is trading 13.4 daily ranges below its 200-day average price (59.6% below it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 13.4 daily ranges below its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.81× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | not available for this company yet | n/a |
Candlestick patterns
2
| Since a hammer | 3 sessions ago, after a stretch of decline, it sold off hard during the session and then closed back near its high — a "hammer", the long lower wick showing the drop was bought back before the close | 3 sessions ago |
|---|---|---|
| Since a bearish engulfing | 2 sessions ago it opened above the previous session's close and finished below that session's open — a "bearish engulfing" pair, where one down day more than undid the up day before it | 2 sessions ago |
Price gaps
3
| Gap at the open | it opened on 2026-10-20 2.7% below the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | -2.7% |
|---|---|---|
| Open gap | it gapped 3.1% below the previous close 4 sessions ago and has not traded back through the level it left behind at 2.28 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | -3.1% |
| Gap filled | a 2.7% gap down opened on 2026-10-20 has been "filled" today — price traded back through the level the gap left behind, and it closed again during the very session that opened it | today |
Price streaks
1
| Closing streak | it has closed lower 3 sessions in a row, a -8.14% move over the run — an unbroken run of down days, which describes what has already happened and says nothing about the next session | 3 sessions down |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 34.2 percentage points (the stock lost 33.2% while the market gained 1.0%) | -34.2% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 51.4 percentage points (the stock lost 47.8% while the market gained 3.6%) | -51.5% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 71.4 percentage points (the stock lost 62.9% while the market gained 8.5%) | -71.4% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 94.8 percentage points (the stock lost 80.2% while the market gained 14.6%) | -94.8% |
Signal agreement
2
| Bullish technical signals | 2 of the 9 technical signals we can compute for it are currently in a bullish state: its RSI momentum gauge is oversold (a beaten-down reading), near the bottom of its 14-day range (oversold) — these describe past price behaviour, not a forecast | 2 of 9 |
|---|---|---|
| Bearish technical signals | 7 of the 9 technical signals we can compute for it are currently in a bearish state: a "death cross" — its 50-day average is below its 200-day, trading below its 200-day average, a fresh 20-day low, MACD momentum is negative, a strong downtrend, with sellers in control, lagging the market over 6 months, trading below the Ichimoku cloud — these describe past price behaviour, not a forecast | 7 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 47% below the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-14 and projected forward over today's price, the side traders read as an established downtrend, with the band above acting as the level that would have to be cleared. The band itself is thick, spanning 51.9% of the share price, which is taken to mean a barrier that has held for a while and takes effort to cross. | -46.8% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 61% below the average price paid so far this year, so the typical buyer over that stretch is under water. That average is $5.25 — a volume-weighted average of daily closes over 198 sessions, not a true tick-by-tick VWAP. | -61.4% |
|---|---|---|
| Vs the average paid since it last reported | the price is 37% below the average price paid since it last reported on 2026-08-04 (its 8-K), so the typical buyer over that stretch is under water. That average is $3.24 — a volume-weighted average of daily closes over 55 sessions, not a true tick-by-tick VWAP. | -37.3% |
Price levels it has turned at before
ASPI last closed at $2.03 on 2026-10-20. Since 2024-10-21 it has turned at 0 prices below its last close and 17 above; the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $3.63 | Resistance | 78.8% above the last close | turned there twice · 2025-03-04 to 2026-07-17 |
| $4.04 | Resistance | 99.3% above the last close | turned there twice · 2024-12-11 to 2026-03-20 |
| $4.90 | Resistance | 141.4% above the last close | turned there twice · 2026-03-05 to 2026-04-29 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 5 of five.
This labelling fails — stops being a possible reading at all — if it closes above $3.06.
It is the only labelling that fits these swings, though its proportions are not the textbook ones. It was chosen from 3 labellings that survived the rules, counting shorter readings of the same bars.
On past moves of this shape the leg has usually ended somewhere between $1.81 and $2.58 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
This reading has stood for 7 trading days, since 2026-10-12.
Read from daily closes as of 2026-10-20.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading below the 200-day moving average · Trading below the 50-day moving average · Oversold (14-day RSI below 30) · Pulled back from the 12-month high · Broke down to a new 20-day low · lagging the market | Learn: moving average · golden cross · adx · rsi · macd · breakout · fifty two week high low
Based on daily closing prices as of 2026-10-20. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Mean price target$13.00 range $11.00 – $15.00
Analyst estimates, as of 2026-10-19. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for ASPI
- Consensus EPS estimate-$0.13 next reporting period, as of 2026-10-19
- Estimate change, 30 days$0.00 from -$0.13, on 2026-09-15, 34-day window
- Readings revised upward22% of 9 comparable readings
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Significant unprofitability and reliance on future commercialization of core technologies to achieve profitability.","Risks associated with pending merger transactions and potential failure to realize anticipated benefits or regulatory approvals.","Operational risks, including equipment performance, commodity price fluctuations, and dependency on successful execution of growth milestones."]
What changed in the latest 10-Q
AI-assisted comparison of ASPI's 10-Q filed 2026-08-14 against the prior one filed 2026-05-20.
Risk Factors
- Added:
- Newer filing adds a 'Risks Related to the ENDRA Merger' section containing three risk factor disclosures (conditions to the Merger, adverse effects if the Merger is not completed, and anticipated benefits of the Merger may not be realized).
- Newer filing adds disclosure that on June 30, 2026, director Michael Gorley adopted a Rule 10b5-1 trading arrangement for sale of up to 23,756 shares, expiring December 18, 2026.
- Newer filing adds disclosure that on June 30, 2026, director Robert Ryan adopted a Rule 10b5-1 trading arrangement for sale of up to 18,274 shares, expiring December 18, 2026.
- Newer filing adds Exhibit 2.1 (Agreement and Plan of Merger dated June 25, 2026 among ENDRA Life Sciences Inc., Kruger Merger Sub LLC, Renergen Limited, Noble Africa LLC and ASP Isotopes Inc.).
- Newer filing adds Exhibit 10.1 (Form of Subscription Agreement, incorporated by reference to Form 8-K filed June 25, 2026).
- Newer filing adds Exhibit 10.2 (Form of Pre-Funded Warrant, incorporated by reference to Form 8-K filed June 25, 2026).
- Newer filing adds Exhibit 10.3 (Form of Voting Agreement, incorporated by reference to Form 8-K filed June 25, 2026).
- Newer filing adds Exhibit 10.4 (Form of Securities Exchange Agreement among ASP Isotopes Inc., Quantum Leap Energy LLC and the person or entity identified on the signature page, incorporated by reference to Form 8-K filed July 16, 2026).
- Newer filing adds Exhibit 10.5 (Non-Employee Director Compensation Policy effective July 1, 2026).
- Removed:
- Older filing's statement that there have been no material changes to risk factors is removed in the newer filing, replaced by 'Except as set forth below' language.
- Older filing's Exhibits 10.1 through 10.29 (Term Loan Facility Agreement addenda, Loan Agreement and amendments, Finance Agreement and amendments, Consents and Waivers, Standard Bank facility agreement, Production Right and Exploration Right documents, LNG Supply Agreement, and Opeongo, Inc. securities agreements) are removed from the newer filing.
- Reworded:
- Older filing states 'other reports that we filed with the SEC' while newer filing states 'other reports that we file with the SEC'.
- Older filing states 'There have been no material changes to our risk factors...' while newer filing states 'Except as set forth below, there have been no material changes to our risk factors...'.
- Older filing covers Rule 10b5-1 trading plans for the three months ended March 31, 2026; newer filing covers the six months ended June 30, 2026.
- Older filing reports no director or officer adopted or terminated a Rule 10b5-1 or non-Rule 10b5-1 trading arrangement during the three months ended March 31, 2026; newer filing reports two directors adopted Rule 10b5-1 trading arrangements.
- Notes:
- The newer filing excerpt appears to be cut off mid-sentence in Exhibit 32.1; the older filing excerpt is also cut off mid-list in Exhibit 31.2. Full exhibit lists were not included in the provided source texts.
- The comparison is based only on the provided excerpts; sections beyond the excerpted text were not available for review.
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
No open-market insider purchases or sales are on record for ASPI — recent Form 4 activity was compensation-related (awards, option exercises, or tax withholding), not open-market buying or selling.
View full insider trading history → View SEC Form 3/4/5 filingsOnly open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
4 institutional 13F filers reported holding ASPI as of 2026-06-30 (quarter-end position, filed within 45 days).
- Distinct 13F filers 4
- Reported shares held 15,256,578
- Reported value $94,895,912
reported quarterly holdings change (2026-03-31 → 2026-06-30): 0 new, 4 increased, 0 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Ask about ASPI's institutional holders → See what each manager we track holds →
Short interest (FINRA)
ASPI had 26,455,716 shares of reported short interest as of the 2026-09-30 FINRA settlement date (delayed, bi-monthly; not real-time).
ASPI had 17.3% of its shares outstanding sold short as of the 2026-09-30 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 5.31 days to cover at the same settlement.
- Reported short interest (shares) 26,455,716
- Short interest (% of shares outstanding) 17.3%
- Prior settlement (shares) 26,069,790
- Reported change 1.48%
- Days to cover (reported) 5.31
Reported to FINRA as of the 2026-09-30 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Urenco
- Centrus Energy (LEU)
- Orano
- Rosatom
- Curium
- BWX Technologies (BWXT)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare ASPI vs…
ASP ISOTOPES INC is found in…
Frequently asked questions
What does ASP ISOTOPES INC (ASPI) do?
ASP Isotopes Inc. is an advanced materials company that develops proprietary technology for the enrichment of isotopes for use in the semiconductor, healthcare, and energy industries. Its operations include a PET Labs group for medical isotopes, the development of stable isotopes like Silicon-28 and Ytterbium-176, nuclear fuel production through its subsidiary Quantum Leap Energy, and helium and LNG production via its interests in Renergen.
What sector is ASP ISOTOPES INC (ASPI) in?
ASP ISOTOPES INC (ASPI) is classified in the Materials sector. Its industry is Advanced Materials & Isotopes. It trades on NASDAQ.
Who are ASP ISOTOPES INC's (ASPI) competitors?
Notable peers of ASP ISOTOPES INC (ASPI) include Urenco, Centrus Energy, Orano, Rosatom and Curium. This peer set is informational only — not financial advice.
Is ASP ISOTOPES INC (ASPI) overbought or oversold right now?
ASP ISOTOPES INC (ASPI) is currently in oversold territory (its 14-day RSI is 26, below 30) (as of 2026-10-20). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on ASPI come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest; prices are market data, as of 2026-09-03; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-20.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.